1. Introduction {#s0005}
===============

Osteoporosis is a serious health problem not only in women but also in men. According to the National Osteoporosis Foundation, about one out of two women and one out of four men over 50 years old will have an osteoporosis-related fracture in their remaining lifetime ([@bb0145]). While the incidence rate is lower in men, men with osteoporosis-related fracture have higher morbidity and mortality rates than women ([@bb0045], [@bb0125]). As the average age of the population continues to increase, the incidence of male osteoporosis is expected to increase significantly. Although many studies of prevention and treatment have been performed in recent years, the pathogenesis of skeletal fragility in men remains unclear.

High-resolution peripheral quantitative computed tomography (HR-pQCT) is a noninvasive approach which enables in vivo 3D analysis of bone microstructure at the appendicular skeleton ([@bb0105], [@bb0140]); this allows the analysis of geometric, microstructural, densitometric, and mechanical properties of the trabecular and cortical bone architecture in the distal radius and tibia ([@bb0035], [@bb0020]). In addition, the application of micro finite-element (μFE) analysis permits the estimation of bone strength ([@bb0025]). How these microstructural and strength parameters relate to areal bone mineral density (BMD) in men is unclear. Further, it is unclear how microstructural and strength parameters are affected by male osteoporosis risk factors including advanced age, low body weight, physical inactivity, hypogonadism, heavy smoking, excessive alcohol consumption, vitamin D deficiency, and inadequate calcium intake ([@bb0165], [@bb0055], [@bb0010]).

In this study, we used HR-pQCT to determine bone microstructure and strength at the distal radius and tibia in 78 older men. (1) We analyzed the relationships between bone microstructure and strength, and male osteoporosis risk factors including age, body mass index (BMI), 25-hydroxyvitamin D (25(OH)D) level, and testosterone level. In addition, we estimated 10-year fracture risk using the fracture risk assessment tool (FRAX) ([@bb0200]) and analyzed the relationships between bone microstructure and FRAX score. (2) Finally, we compared bone microstructure and strength measures of men with normal, low, and osteoporosis-range areal BMD (aBMD).

2. Materials and methods {#s0010}
========================

2.1. Subjects {#s0015}
-------------

The subjects consisted of 78 healthy male volunteers. The recruitment was done using electronic kiosk announcements and flyers posted in the San Francisco VA Medical Center (San Francisco, USA), and weekly internet advertisements. We excluded men who had been treated with either an oral bisphosphonate or teriparatide in the last year or for \> 12 months ever, and those who had diseases or took medications known to affect bone metabolism, including current use of testosterone therapy, and use of prednisone \> 5 mg daily or the equivalent glucocorticoid for \> 10 days in the last 3 months. Other exclusion criteria included alcohol use \> 3 drinks/day, serum calcium level \> 10.2 mg/dL, and estimated glomerular filtration rate \< 30 mL/min/1.73m^2^.

The study protocol was approved by the UCSF Committee on Human Research and complied with the Declaration of Helsinki of 1975, revised in 2000, and written informed consent was obtained before participation.

2.2. Biochemical measurements {#s0020}
-----------------------------

Blood samples were collected from all subjects. Serum calcium and creatinine levels were measured on the Beckman Coulter (Fullerton, CA) DXC800 instrument using a Synchron assay. 25(OH)D was measured by electrochemiluminescent immunoassay (DiaSorin LIAISON). Serum total testosterone was determined using the Access testosterone assay (Beckman Coulter).

2.3. Areal bone mineral density and FRAX {#s0025}
----------------------------------------

Areal BMD (aBMD) was measured by dual-energy X-ray absorptiometry (DXA) (GE Lunar DXA, GE Healthcare Systems, Wauwatosa, WI, USA) at the lumbar spine (L1 to L4), non-dominant hip (total hip and femoral neck), and radius (distal one-third, ultra distal, and total).

The 10-year probabilities of major osteoporotic fracture (hip, proximal humerus, distal radius, or clinical spine fracture) and hip fracture were estimated using FRAX (version 3.9).

2.4. HR-pQCT and image-based μFEA of the ultra-distal radius and tibia {#s0030}
----------------------------------------------------------------------

All subjects were imaged in a clinical HR-pQCT system (XtremeCT, Scanco Medical AG, Brüttisellen, Switzerland) using the manufacturer\'s standard in vivo protocol described in previous patient studies ([@bb0180], [@bb0075], [@bb0120]). The subject\'s forearm and ankle were immobilized in a carbon fiber cast that was fixed within the gantry of the scanner. A single dorsal-palmar projection image of the distal radius and tibia was acquired to define the tomographic scan region. This region spanned 9.02 mm in length (110 slices) and was fixed starting proximally at 9.5 and 22.5 mm from a joint margin reference line for ultra-distal radius (UDR) and ultra-distal tibia (UDT), respectively. For tomography, 750 projections were acquired over 180 degrees with a 100-ms integration time at each angular position. The 12.6-cm field of view (FOV) was reconstructed across a 1536 × 1536 matrix using a modified Feldkamp algorithm, yielding 82-μm voxels ([@bb0060]). Total scan time was 2.8 min with an equivalent dose of approximately 4.2 μSv for each site.

2.5. Image analysis {#s0035}
-------------------

### 2.5.1. Image quality grading for motion artifacts {#s0040}

The severity of motion artifacts was graded according to the manufacture-suggested image quality grading system. Grading was performed in 3 slices (at the middle and both proximal and distal end slices) of the reconstructed images, and the images with grades 4 and 5 were excluded ([@bb0170]). One case in UDR was excluded due to motion artifact. Therefore, 77 cases of UDR and 78 cases of UDT were available for analysis.

2.6. Standard analysis {#s0045}
----------------------

All image analysis was performed using the standard clinical evaluation protocol in Image Processing Language (IPL Version 5.08b, Scanco Medical AG), as described in detail in previous publications ([@bb0075], [@bb0190]). Contours identifying the periosteal perimeter of the bone were drawn semiautomatically using a chaperoned iterative contouring procedure. All contours were examined manually and modified as necessary to delineate the periosteal boundary. Integral volumetric BMD was quantified based on the periosteal segmentation. A threshold-based process was used to segment cortical and trabecular regions for compartment-specific measurements of density and structure ([@bb0105]). Trabecular bone volume fraction (BV/TV) was calculated based on trabecular BMD (Tb.BMD) assuming a tissue mineral density of 1200 mg HA/cm^3^. Trabecular number (Tb.N) was calculated directly by a model-independent sphere fitting technique ([@bb0070], [@bb0100]). Based on the calculated BV/TV and Tb.N values, trabecular separation (Tb.Sp) and trabecular thickness (Tb.Th) were derived using standard histomorophometric relations assuming a plate model ([@bb0095]).

2.7. Cortical analysis {#s0050}
----------------------

Cortical bone microstructure parameters at ultra-distal sites were assessed using an extended cortical bone analysis that provides direct calculation of cortical thickness, as well as measures of porosity ([@bb0030], [@bb0040]). Values for the following structural parameters were calculated: cortical BMD (Ct.BMD), cortical thickness (Ct.Th), cortical porosity (Ct.Po), and cortical pore diameter (Po.Dm). Ct.BMD was calculated as the mean value of all voxels within the cortical compartment, following partial volume suppression (2 voxels) at the periosteal and endosteal surfaces. Ct.Po was defined as the fraction of the segmented pore volume over the sum of the pore and cortical bone volume.

2.8. Micro-finite element analysis (μFEA) {#s0055}
-----------------------------------------

Linear μFEA was used to calculate apparent biomechanical properties at each site. Homogeneous mechanical properties were assumed for all bone elements. The binary image data set was converted to a mesh of voxels (isotropic) using a conversion technique ([@bb0135]), and each element was assigned an elastic modulus of 6.829 GPa ([@bb0025]) and a Poisson\'s ratio of 0.3 ([@bb0195]). Cortical and trabecular bone elements were labeled as different materials, with identical material properties to facilitate calculation of compartmental load distribution. A uniaxial compression test in the axial direction (superior-inferior) was performed with an applied uniaxial compressive strain of 1%. An iterative solver (Scanco FE software v.1.15; Scanco Medcal AG, Brüttisellen, Switzerland) was used to compute reaction forces at the proximal and distal ends of the scan region for the proscribed displacements. For each model, stiffness (K), apparent modulus (E), and the load fraction for the cortical compartment at the distal boundary (Ct.LF dist) and the proximal boundary (Ct.LF prox) were calculated. Furthermore, failure load (F) was estimated using methods previously described by [@bb0130].

2.9. Statistical analysis {#s0060}
-------------------------

Statistical analyses were performed using SPSS version 16.0 (SPSS, Chicago, IL, USA).(1)The relationships between the bone microstructure and μFEA parameters, and age, BMI, 25(OH)D, and testosterone were analyzed by Pearson\'s correlation coefficient test. The relationships between the bone microstructure and μFEA parameters, and FRAX score (the 10-year probability of a major osteoporotic fracture and of a hip fracture) were analyzed in the same way. The level of statistical significance was established at *p* \< 0.05.(2)All subjects were classified as having normal, low, or osteoporosis-range BMD according to World Health Organization (WHO) categories based on DXA T-score at lumbar spine, total hip and femoral neck: normal aBMD if lowest T-score ≥ − 1.0; low bone mass ("osteopenia") if − 2.5 \< T-score \< − 1.0; osteoporosis if T-score ≤ − 2.5 ([@bb0200]). We compared the bone microstructure and μFEA parameters between the normal group and osteopenic or osteoporotic groups. A Bonferroni correction was used to account for multiple comparisons, therefore the level of statistical significance was set at *p* \< 0.025.

3. Results {#s0065}
==========

The mean age of 78 subjects was 62.4 ± 7.8 years (range 50--84 years). Forty-four men (56%) were white, 18 (23%) were African American, 11 (14%) were Asian, 4 (5%) were Hispanic, and 1 (1%) was American Indian. The mean BMI was 27.1 ± 3.2 kg/m^2^, testosterone was 423.2 ± 165.1 ng/dL, and 25(OH)D level was 23.2 ± 9.6 ng/mL. Trabecular and cortical bone microstructure parameters and μFEA parameters at UDR and UDT are displayed in [Table 1](#t0005){ref-type="table"}, with representative 3D images of cortical bone in [Fig. 1](#f0005){ref-type="fig"}.Fig. 13D visualization of cortical bone at the ultra-distal radius (A and B) and tibia (C and D). Intracortical porosity was increase in elderly subjects (B and D).Fig. 1Table 1Bone microstructure and μFEA parameters of the ultra distal radius and the ultra distal tibia.Table 1ParameterRadius (n = 77)Tibia (n = 78)MeanSDMinMaxMeanSDMinMaxTb.Th (μm)751153101791252108Tb.N (/mm)2.000.281.362.461.940.311.212.66Tb.Sp (μm)4347632065144888294725Tb.BMD (mg/cm^3^)1813710425818435109263Ct.Th (mm)0.970.170.611.531.400.260.892.21Ct.Po (%)2.91.31.18.27.02.61.916.7Po.Dm (μm)1722114324019123152307Ct.BMD (mg/cm^3^)924457351017881557351001Stiffness, *K* (kN/mm)68.613.138.6105.3172.830.2103.7281.4Modulus, *E* (N/m^2^)1290285696198516143048612186Failure load, *F* (N)40577262350617699821697627516112Ct.LF-dist (%)41.27.428.767.144.17.328.062.5Ct.LF-prox (%)79.15.863.390.966.66.950.084.9

3.1. The relationships between bone microstructure parameters and risk factors of male osteoporosis. {#s0070}
----------------------------------------------------------------------------------------------------

BMI was significantly correlated with total hip, femoral neck, total radius, and 1/3 radius T-scores by DXA, such that those with higher BMI had higher DXA T-scores ([Table 2](#t0010){ref-type="table"}). By HR-pQCT, at the UDR, age had a significant positive correlation with Ct.Po (*r* = 0.36, *p* = 0.001, [Table 2](#t0010){ref-type="table"}, [Fig. 2](#f0010){ref-type="fig"}), such older participants had greater cortical porosity. At the UDT, age was positively correlated with Ct.Po (*r* = 0.47, *p* \< 0.001, [Table 2](#t0010){ref-type="table"}, [Fig. 2](#f0010){ref-type="fig"}) and negatively correlated with Ct.BMD (*r* = − 0.40, *p* \< 0.001), whereas it was positively correlated with Tb·BMD (*r* = 0.30, *p* = 0.008). BMI was correlated with Tb.N, Tb.Sp, and Ct.Th at UDT, such that those with higher BMI had higher Tb.N, lower Tb.Sp, and higher Ct.Th. Cortical porosity was increased significantly with aging, particularly at the UDT. In addition, age was negatively correlated with Ct.LF-prox and Ct.LF-dist (*r* = − 0.48, *p* \< 0.001 and *r* = − 0.36, *p* = 0.001, respectively). Age was not correlated with stiffness, apparent modulus, or failure load.Fig. 2Correlation between Ct.Po and age. Ct.Po changed significantly with aging, particularly at the tibia.Fig. 2Table 2Correlation between DXA T-score and bone microstructure, and age, BMI, serum testosterone, 25(OH)D levels, and FRAX score.Table 2AgeBMITestosterone25(OH)DFRAX scoreMajor osteoporotic fractureHip fractureDXAL1-L40.080.130.120.03----Total Hip0.070.36 \*\*0.09− 0.02----Femoral Neck− 0.030.30 \*\*0.09− 0.07----Total Radius− 0.090.28 \*0.01− 0.12----1/3 Radius− 0.110.25 \*0.03− 0.10----UDR T-Score0.000.180.00− 0.09----  RadiusTb.Th0.04− 0.09− 0.020.07− 0.15− 0.16Tb.N0.120.190.11− 0.11− 0.20− 0.27 \*Tb.Sp− 0.17− 0.17− 0.090.080.200.28 \*Tb.BMD0.110.080.05− 0.01− 0.22 \*− 0.28 \*Ct.Th− 0.02− 0.040.15− 0.04− 0.37 \*\*− 0.22Ct.Po0.36 \*\*0.04− 0.090.040.30 \*\*0.27 \*Po.Dm0.26 \*− 0.040.060.180.200.22Ct.BMD− 0.18− 0.090.160.05− 0.27 \*− 0.17Stiffness, *K*0.040.040.13− 0.01− 0.50 \*\*− 0.42 \*\*Modulus, *E*0.04− 0.030.110.07− 0.34 \*\*− 0.27 \*Failure load, *F*0.050.060.12− 0.03− 0.50 \*\*− 0.44 \*\*Ct.LF-dis− 0.28 \*0.030.10− 0.09− 0.17− 0.06Ct.LF-prox− 0.25 \*− 0.010.00− 0.100.060.20  TibiaTb.Th0.15− 0.08− 0.040.20− 0.04− 0.14Tb.N0.24 \*0.33 \*\*0.00− 0.12− 0.20− 0.18Tb.Sp− 0.25 \*− 0.32 \*\*− 0.010.130.180.19Tb.BMD0.30 \*\*0.22− 0.020.06− 0.19− 0.25 \*Ct.Th− 0.110.31 \*\*− 0.07− 0.17− 0.46 \*\*− 0.37 \*\*Ct.Po0.47 \*\*0.02− 0.030.29 \*0.220.20Po.Dm0.20− 0.150.060.29 \*0.180.14Ct.BMD− 0.40 \*\*0.040.07− 0.22 \*− 0.34 \*\*− 0.29 \*\*Stiffness, *K*0.090.22 \*0.02− 0.11− 0.48 \*\*− 0.46 \*\*Modulus, *E*0.020.15− 0.05− 0.03− 0.35 \*\*− 0.35 \*\*Failure load, *F*0.100.22 \*0.02− 0.11− 0.47 \*\*− 0.45 \*\*Ct.LF-dist− 0.48 \*\*0.190.03− 0.30 \*\*− 0.24 \*− 0.08Ct.LF-prox− 0.36 \*\*0.16− 0.02− 0.22− 0.17− 0.09[^1]

At the UDR, those with lower Tb.BMD, Ct.BMD, and Ct.Th, and higher Ct.Po had higher FRAX scores for major osteoporotic fracture; those with lower Tb.BMD and Tb.N, and higher Tb.Sp and Ct.Po had higher FRAX scores for hip fracture. On the other hand, at the UDT, those with lower Ct.BMD and Ct.Th had higher FRAX score for major osteoporotic fracture and hip fracture; those with lower Tb.BMD had also higher FRAX score for hip fracture. At both the UDR and UDT, those with lower stiffness, apparent modulus, and failure load had higher FRAX score for major osteoprotic fracture and hip fracture, such that those with lower estimated bone strength had higher FRAX scores.

When bone microstructure and μFEA parameters were examined with DXA T-scores, DXA T-scores were significantly correlated with trabecular bone parameters (Tb.N, Tb.Sp, and Tb.BMD) and Ct.Th at the spine, proximal femur, and radius ([Table 3](#t0015){ref-type="table"}). In addition, T-score at the total and ultradistal radius had a significant correlation with Tb.Th and Ct.BMD at the UDR, and with Ct.BMD and Po.Dm at the UDT. In contrast, there was no significant relationship between DXA T-score and Ct.Po at either anatomic site. In μFEA parameters, DXA T-score of all sites had significant correlation with stiffness, apparent modulus, and failure load, such that those with higher T-scores had greater estimated bone strength.Table 3Correlation between bone microstructure and μFEA parameters, and DXA T-score.Table 3L-spineHipRadiusL1--L4Total hipNeckTotal radius1/3 RadiusUDRRadiusTb.Th0.120.100.080.44 \*\*0.210.53 \*\*Tb.N0.33 \*\*0.52 \*\*0.44 \*\*0.33 \*\*0.170.46 \*\*Tb.Sp− 0.35 \*\*− 0.54 \*\*− 0.45 \*\*− 0.37 \*\*− 0.19− 0.51 \*\*Tb.BMD0.30 \*\*0.43 \*\*0.35 \*\*0.53 \*\*0.26 \*0.68 \*\*Ct.Th0.34 \*\*0.27 \*0.31 \*\*0.54 \*\*0.34 \*\*0.60 \*\*Ct.Po0.01− 0.07− 0.06− 0.11− 0.07− 0.16Po.Dm− 0.09− 0.05− 0.01− 0.17− 0.08− 0.16Ct.BMD0.130.120.130.29 \*\*0.180.38 \*\*Stiffness, *K*0.57 \*\*0.57 \*\*0.61 \*\*0.79 \*\*0.63 \*\*0.87 \*\*Modulus, *E*0.37 \*\*0.32 \*\*0.30 \*\*0.58 \*\*0.33 \*\*0.71 \*\*Failure load, *F*0.57 \*\*0.59 \*\*0.63 \*\*0.79 \*\*0.64 \*\*0.86 \*\*Ct.LF-dis0.04− 0.040.000.040.000.02Ct.LF-prox− 0.27 \*− 0.33 \*\*− 0.29 \*− 0.23 \*− 0.22− 0.28 \*  TibiaTb.Th0.120.200.110.160.090.24 \*Tb.N0.39 \*\*0.60 \*\*0.54 \*\*0.43 \*\*0.32 \*\*0.49 \*\*Tb.Sp− 0.40 \*\*− 0.60 \*\*− 0.52 \*\*− 0.42 \*\*− 0.31 \*\*− 0.50 \*\*Tb.BMD0.43 \*\*0.64 \*\*0.53 \*\*0.48 \*\*0.33 \*\*0.59 \*\*Ct.Th0.34 \*\*0.55 \*\*0.53 \*\*0.62 \*\*0.49 \*\*0.58 \*\*Ct.Po− 0.04− 0.02− 0.02− 0.16− 0.13− 0.14Po.Dm− 0.14− 0.15− 0.13− 0.29 \*\*− 0.18− 0.27 \*Ct.BMD0.180.24 \*0.23 \*0.37 \*\*0.30 \*\*0.35 \*\*Stiffness, *K*0.61 \*\*0.71 \*\*0.74 \*\*0.72 \*\*0.63 \*\*0.74 \*\*Modulus, *E*0.35 \*\*0.50 \*\*0.44 \*\*0.55 \*\*0.41 \*\*0.60 \*\*Failure load, *F*0.60 \*\*0.71 \*\*0.74 \*\*0.71 \*\*0.62 \*\*0.73 \*\*Ct.LF-dist− 0.12− 0.06− 0.030.050.02− 0.02Ct.LF-prox− 0.19− 0.07− 0.080.030.02− 0.05[^2]

3.2. Comparison of men with normal, low, and osteoporosis-range aBMD. {#s0075}
---------------------------------------------------------------------

Of the 78 men studied, 40 had normal aBMD on DXA, 32 had low bone mass on DXA, and 6 had osteoporosis-range aBMD ([Table 4](#t0020){ref-type="table"}). There was no significant difference in age or BMI between the three groups.Table 4Mean values ± SD and differences between normal, osteopenia and, osteoporosis.Table 4RadiusNormal (1)\
(n = 39)Osteopenia (2)\
(n = 32)Osteoporosis (3)\
(n = 6)*p*1 vs 21 vs 3Age (years)63.1 ± 7.162.0 ± 8.362.0 ± 9.1NSNSBMI27.5 ± 3.126.9 ± 3.525.7 ± 2.3NSNSTb.Th (μm)75.0 ± 9.674.3 ± 11.976.0 ± 15.5NSNSTb.N (/mm)2.10 ± 0.221.94 ± 0.301.77 ± 0.21\*\*Tb.Sp (μm)407 ± 54454 ± 86498 ± 75\*\*Tb.BMD (mg/cm^3^)191 ± 31173 ± 40158 ± 39NSNSCt.Th (mm)1.00 ± 0.160.95 ± 0.180.88 ± 0.18NSNSCt.Po (%)2.9 ± 1.12.8 ± 1.43.4 ± 1.7NSNSPo.Dm (μm)172 ± 23170 ± 17183 ± 30NSNSCt.BMD (mg/cm^3^)928 ± 39923 ± 51910 ± 53NSNSStiffness, *K* (kN/mm)74.4 ± 12.364.5 ± 10.653.3 ± 11.2\*\*\*\*Modulus, *E* (N/m^2^)1369 ± 2481226 ± 2841118 ± 390NSNSFailure load, *F* (N)4380 ± 6793829 ± 5793165 ± 568\*\*\*\*Ct.LF-dis (%)40.8 ± 7.042.1 ± 7.838.5 ± 8.3NSNSCt.LF-prox (%)77.6 ± 5.180.6 ± 6.080.8 ± 7.0NSNS  TibiaNormal (1)\
(n = 40)Osteopenia (2)\
(n = 32)Osteoporosis (3)\
(n = 6)*p*1 vs 21 vs 3Age (years)62.9 ± 7.362.0 ± 8.362.0 ± 9.1NSNSBMI27.4 ± 3.126.9 ± 3.525.7 ± 2.3NSNSTb.Th (μm)81.0 ± 10.577.8 ± 13.677.3 ± 13.3NSNSTb.N (/mm)2.07 ± 0.301.85 ± 0.261.62 ± 0.08\*\*\*\*Tb.Sp (μm)413 ± 79476 ± 84540 ± 38\*\*\*\*Tb.BMD (mg/cm^3^)200 ± 31171 ± 32151 ± 29\*\*\*\*Ct.Th (mm)1.47 ± 0.261.34 ± 0.231.27 ± 0.37NSNSCt.Po (%)6.8 ± 2.57.2 ± 2.27.6 ± 4.6NSNSPo.Dm (μm)187 ± 18193 ± 20206 ± 52NSNSCt.BMD (mg/cm^3^)891 ± 53869 ± 54867 ± 71NSNSStiffness, *K* (kN/mm)188.3 ± 28.1160.9 ± 21.3132.9 ± 19.8\*\*\*\*Modulus, *E* (N/m^2^)1709 ± 2541524 ± 2981458 ± 469\*NSFailure load, *F* (N)10853 ± 15859324 ± 11767684 ± 1000\*\*\*\*Ct.LF-dist (%)43.3 ± 7.144.3 ± 7.448.1 ± 8.3NSNSCt.LF-prox (%)65.4 ± 6.467.5 ± 7.169.7 ± 9.3NSNS[^3]

At the UDR, men with low bone mass and osteoporotic men had significantly lower Tb.N, higher Tb.Sp, and lower stiffness and failure load than normal men. At the UDT, men with low bone mass and osteoporotic men had lower Tb.N and Tb.BMD, higher Tb.Sp, and lower stiffness and failure load. In addition, men with low bone mass had lower modulus. At both UDR and UDT, there was no significant difference in cortical bone microstructure parameters (Ct.Th, Ct.Po, Po.Dm, and Ct.BMD).

4. Discussion {#s0080}
=============

In the present study, we examined not only the relationships between bone microstructure, aBMD by DXA, FRAX scores, and risk factors for male osteoporosis in healthy men over 50 years old, but also microstructural differences between men with normal, low, and osteoporosis-range aBMD.

Aging is recognized as the most important risk factor for male osteoporosis ([@bb0010]). We observed that age had a correlation with microstructure; cortical porosity and cortical bone mineral density were affected by age, especially at the tibia, a weight-bearing site ([Table 2](#t0010){ref-type="table"}). Our findings were similar to those of [@bb0150], who compared the bone microstructure of the distal radius and tibia in men under vs. over the age of 50 using HR-pQCT; they reported that cortical porosity was significantly higher in older men, while there was not a significant difference between younger and older men in trabecular bone microstructure. In contrast, when [@bb0065] reported age-related change of bone microstructure at the radius and tibia in men aged 20 to 80 years using HR-pQCT, they showed that trabecular bone as well as cortical bone were weakened with aging. In our study, tibial cortical bone microstructure was weakened and load fraction for the cortical compartment was decreasing with aging. Conversely, trabecular bone microstructure became stronger with aging, albeit with a weak correlation. Furthermore, there was no relationship between bone strength and age. Therefore, these findings raise the possibility that while cortical bone is weakened with aging, bone strength is maintained with compensatory strengthening of trabecular bone microstructure. However, our observations were limited to a cohort of men ages 50--84 years.

Aging presumably affects the bones in a number of ways, including telomere shortening ([@bb0015]), reduced secretion of the sex steroids such as testosterone or estrogen ([@bb0085]), and a decrease in muscle mass ([@bb0185]). We did not observe a significant relationship between serum testosterone levels and bone microstructure, but it has been shown previously that the age-related decline of estrogen has a stronger effect on the bone compared to testosterone ([@bb0090]).

[@bb0115] reported that lower serum vitamin D levels significantly increase the risk of hip fracture in men and women over 65 years old. In that study of people over the age of 65, the prevalence of vitamin D deficiency is high; 26% of them had serum 25(OH)D level under 20 ng/mL ([@bb0160]). In our study, 30% of all cases had serum vitamin D deficiency (data not shown). We also detected 25(OH)D level had an unexpected modest positive association with cortical porosity, and a negative association with Ct.BMD at the tibia. We suspect that these associations may have been confounded by age, as age was positively associated with both 25(OH)D level (*r* = 0.26, *p* = 0.02, data not shown) and cortical porosity, and negatively associated with Ct.BMD.

Although BMI was weakly correlated with BMD of the hip and radius, it was not correlated with BMD at the lumbar spine ([Table 2](#t0010){ref-type="table"}). Additionally, in microstructure parameters, BMI was weakly correlated with Tb.N, Tb.Sp and Ct.Th in UDT ([Table 2](#t0010){ref-type="table"}). It is reported that BMI is positively associated with BMD of femoral neck in men and women ([@bb0110]). Furthermore, low BMI is recognized as a risk factor for hip fracture being independent of BMD, while low BMI is not an independent risk factor for the fracture of the other sites ([@bb0050]). In our study, we recognized the relationships between BMI and bone microstructure at the tibia but not at the radius; BMI might have more influence on the bone microstructure at the weight-bearing site than at the non weight-bearing site.

There has been no published report showing the relationship between the FRAX score and bone microstructure. The 10-year probability of a major osteoporotic or hip fracture had significant relationships with cortical parameter, especially at the UDT. Similarly, FRAX score had significant relationships with bone strength. Future research should determine whether cortical bone microstructure and strength may actually improve the predictive ability of the FRAX model or be an alternate tool for fracture risk prediction.

Cortical porosity is attributed to bone resorption on the endocortical surface and on the surface of Haversian and Volkman canals ([@bb0080], [@bb0205]). As the cortical porosity progresses, bone mechanical strength is lowered ([@bb0175]). [@bb0155] compared the microstructure differences between postmenopausal women with normal, low, or osteoporosis-range aBMD; it was shown that women with both low bone mass and osteoporosis had lower Ct.Th and greater Ct.Po. In the present study, we compared men over 50 years old with normal, low, or osteoporosis-range aBMD. Men with osteoporosis and low bone mass had trabecular bone fragility and lower bone strength in both distal radius and tibia; however, there were no significant differences in cortical bone microstructure at the both sites ([Table 4](#t0020){ref-type="table"}). In addition, DXA T-score had no correlation with Ct.Po ([Table 3](#t0015){ref-type="table"}); therefore, DXA is likely not sensitive enough to capture differences in cortical porosity in elderly men. We observed a relatively strong relationship between DXA aBMD and trabecular bone parameters. However, the FRAX score had a stronger relationship with cortical bone parameters compared to trabecular bone parameters, despite the fact that FRAX was calculated from aBMD. A cohort study by [@bb0005] found Ct.Po at the ultra-distal radius was an independent discriminator of forearm fracture in osteopenic, but not osteoporotic women. Therefore, Ct.Po measured by HR-pQCT could provide unique information relevant to fracture discrimination, while trabecular bone microstructure measures may not add significant power beyond aBMD.

This study has several limitations. First, our sample size is small, particularly in the category of men with osteoporosis-range bone mass on DXA. Second, this was cross-sectional study with men over 50 years of age, which precluded comparisons with a cohort of women, as well as age related changes in bone microstructure. Third, the voxel size of 82 μm is greater than the diameter of some cortical pores and therefore the porosity measures do not reflect small pores; the approach was also limited by the established accuracy and reproducibility of porosity measures using HR-pQCT ([@bb0190], [@bb0040], [@bb0155]). However macroscopic porosity is well correlated to integral porosity across all scales ([@bb0190]).

In conclusion, age had a stronger correlation with bone microstructure than other risk factors for male osteoporosis. Cortical bone microstructure was negatively affected by aging, and there was a suggestion that the influence of aging may be particularly important at the weight-bearing sites. Bone strength might be maintained during aging by means of the compensatory strengthening of trabecular bone. When we compared the men with normal, low, and osteoporosis-range aBMD, men with osteoporosis and low bone mass had significantly weak trabecular bone microstructure and bone strength at both the distal radius and tibia, but no significant differences in cortical bone parameters at both sites. Tb.BMD is not really independent of aBMD and therefore will not likely identify those in these groups that are at high risk of fracture. On the other hand, Ct.Po may provide unique discriminatory power in addition to aBMD, based on its poor correlation to aBMD and strong correlation with aging.
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[^1]: Pearson\'s correlation coefficient \**p* \< 0.05, \*\**p* \< 0.01.

[^2]: Pearson\'s correlation coefficient \**p* \< 0.05, \*\**p* \< 0.01.

[^3]: Boneferroni correction, \**p* \< 0.025, \*\**p* \< 0.005, NS = not significant.
